Incidence and mortality trends of Male reproductive system Cancers in Sri Lanka: a population-based study

dc.contributor.authorWeerasekara, W. M. O. V. K.
dc.contributor.authorWijerathne, A. G. A. N.
dc.contributor.authorJayakod, S. L.
dc.contributor.authorSoysa, N. S.
dc.date.accessioned2026-11-20T11:12:31Z
dc.date.available2026-11-20T11:12:31Z
dc.date.issued2026-08-20
dc.description.abstractMale reproductive system cancers including prostate, testicular and penile cancers, contributesignificantly to the global cancer burden. Among these, Prostate cancer (PC) is the most commonlydiagnosed malignancy and the fifth leading cause of cancer-related mortality among men worldwide.In Sri Lanka, data on long-term trends of male reproductive system cancers remain limited. Therefore,this study aimed to describe the incidence and patterns of these cancers. The data were extracted fromthe Cancer Incidence and Mortality Database of Sri Lanka (Sri Lanka Cancer Registry) maintained bythe National Cancer Control Programme (NCCP), Ministry of Health, Sri Lanka, from 2005 to 2022.Male reproductive system cancers were defined using ICD-10 classification and categorized into penile(C60), prostate (C61), testicular (C62) and other male genital organ cancers (C63). These data wereused to estimate the incidence rates, including crude incidence rate (CR) and age-standardized incidencerate (ASIR). Trends in the ASIR, Annual Percentage Change (APC), and Average Annual PercentageChange (AAPC) were assessed using join-point regression. According to the data, male reproductivesystem cancers demonstrated a changing pattern over time. Between 2005 and 2022, a total of 16,930cases were recorded with an AAPC of 8.19%. PC accounted for the majority of cases (n=13,849)followed by penile (n=1807), testicular (n=1133) and other genital cancers (n=141). Prevalence ofcancers in the prostate, testis, penis, and other genital organs increased from 7.16% in 2005 to 8.62%in 2022. ASIR for prostate cancer increased markedly from 3.5 in 2005 to 11.1 per 100,000 in 2022,with an AAPC of 8.08%. Moreover, the AAPC for testicular cancers, penile cancers, and other genitalcancers were 3.82%, 1.09%, and 5.71% respectively. Age-Standardized Mortality Rate (ASMR) for PCin Sri Lanka increased from 1.0 in 2005 to 3.26 per 100,000 in 2021 (AAPC = 6.21%). These findingshighlight a growing burden of prostate cancer and other genital cancers in Sri Lanka, emphasizing theneed for enhanced early detection, targeted screening, and effective management strategies to reducemorbidity and mortality.
dc.identifier.citationProceedings of the Peradeniya University International Research Sessions (iPURSE) – 2026, University of Peradeniya, Sri Lanka, P. 98
dc.identifier.isbn978-624-1234-56-7
dc.identifier.issnE-ISSN 1391-4111
dc.identifier.urihttps://ir.lib.pdn.ac.lk/handle/20.500.14444/8318
dc.language.isoen_US
dc.publisherUniversity of Peradeniya, Sri Lanka
dc.subjectProstate cancer
dc.subjectMale reproductive system cancers
dc.subjectCancer incidence
dc.subjectSri Lanka
dc.subjectAgestandardized rate
dc.titleIncidence and mortality trends of Male reproductive system Cancers in Sri Lanka: a population-based study
dc.typeAbstract

Files

Original bundle

Now showing 1 - 1 of 1
Loading...
Thumbnail Image
Name:
Weerasekara W. M. O. V. K. iPURSE 2026.pdf
Size:
270.88 KB
Format:
Adobe Portable Document Format

License bundle

Now showing 1 - 1 of 1
Loading...
Thumbnail Image
Name:
license.txt
Size:
1.71 KB
Format:
Item-specific license agreed to upon submission
Description:

Collections